RÉSUMÉ
Activation of the ERK1/2 pathway is involved in malignant transformation both in vitro and in vivo. Little is known about the role of activated ERK1/2 in non-small cell lung cancer (NSCLC). The purpose of this study was to characterise the extent of the activation of ERK1/2 by immunohistochemistry in patients with NSCLC, and to determine the relationship of ERK1/2 activation with clinicopathological variables. Specimens from 111 patients with NSCLC (stages I-IV) were stained for P-ERK. Staining for epidermal growth factor receptor (EGFR) and Ki-67 was also performed. In all, 34% of the tumour specimens showed activation for ERK1/2, while normal lung epithelial tissue was consistently negative. There was a strong statistical correlation between nuclear and cytoplasmic P-ERK staining and advanced stages (P<0.05 and P<0.001, respectively), metastatic hilar or mediastinal lymph nodes (P<0.01, P<0.001), and higher T stages (P<0.01, P<0.001). We did not find correlation of nuclear or cytoplasmic P-ERK staining with either EGFR expression or Ki-67 expression. Total ERK1/2 expression was evaluated with a specific ERK1/2 antibody and showed that P-ERK staining was not due to ERK overexpression but rather to hyperactivation of ERK1/2. Patients with a positive P-ERK cytoplasmic staining had a significant lower survival (P<0.05). However, multivariate analysis did not show significant survival difference. Our study indicates that nuclear and cytoplasmic ERK1/2 activation positively correlates with stage, T and lymph node metastases, and thus, is associated with advanced and aggressive NSCLC tumours.
Sujet(s)
Carcinome pulmonaire non à petites cellules/métabolisme , Tumeurs du poumon/métabolisme , Métastase lymphatique/anatomopathologie , Mitogen-Activated Protein Kinase 1/métabolisme , Mitogen-Activated Protein Kinases/métabolisme , Adénocarcinome/métabolisme , Adénocarcinome/anatomopathologie , Adénocarcinome/secondaire , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Carcinome pulmonaire non à petites cellules/anatomopathologie , Carcinome épidermoïde/métabolisme , Carcinome épidermoïde/anatomopathologie , Carcinome épidermoïde/secondaire , Noyau de la cellule/métabolisme , Cytoplasme/métabolisme , Activation enzymatique , Épithélium/métabolisme , Récepteurs ErbB/métabolisme , Femelle , Humains , Techniques immunoenzymatiques , Antigène KI-67/métabolisme , Poumon/métabolisme , Tumeurs du poumon/anatomopathologie , Mâle , Tumeurs du médiastin/métabolisme , Tumeurs du médiastin/anatomopathologie , Tumeurs du médiastin/secondaire , Adulte d'âge moyen , Mitogen-Activated Protein Kinase 3 , Stadification tumorale , PhosphorylationRÉSUMÉ
The aim of this study was to identify which cell types of the rat gastric epithelium express neuronal nitric oxide synthase (nNOS) because the results of the previous studies have been very divergent regarding this point. By the combination of immunohistochemical (IHC) and in situ hybridization (ISH) techniques, we detected expression of nNOS in chief and mucosecretory cells of the gastric epithelium. Moreover, some gastric endocrine cells were immunoreactive for nNOS, although they could not be distinguished in sections treated with ISH techniques. The strongest signal for all antibodies in IHC techniques was obtained when microwave (MW) heating was performed before the IHC procedure. Our results indicate that in the gastric epithelium a variety of cell types are able to produce NO. The NO produced by the different cell types (chief, mucous, and endocrine) may form a complex network of paracrine communication with an important role in gastric physiology.
Sujet(s)
Cellules épithéliales/enzymologie , Muqueuse gastrique/enzymologie , Nitric oxide synthase/métabolisme , Animaux , Cellules épithéliales/cytologie , Muqueuse gastrique/cytologie , Immunohistochimie , Hybridation in situ , Nitric oxide synthase type I , ARN messager/métabolisme , Rats , Rat Wistar , RT-PCRRÉSUMÉ
We report four cases with syndrome of asymmetric crying facies, analyzing particularly the etiology, embryology, and incidence of the congenital hypoplasia of depressor anguli oris muscle. In one of the cases, with multiple malformations, the patient had an abnormal karyotype, 47,XX, +i(18p). We stress the high incidence of associations with congenital malformations (eight fold the general population) and more specifically with congenital heart disease, musculoskeletal, and genito-urinary defects. The diagnosis of MDAO agenesis is basically clinic, being as differential diagnosis the paralysis of the 7th cranial nerve, defining it with electrophysiological techniques.